IB Investment Groupsp. z o.o.

Organisation of conventions and trade shows

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-06-02
Share capital
10,000.00 PLN
Registered address
ul. Zagrody 78, 32-800 Okocim, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 91 days for 2021).

  • 2025not filed
  • 202415/07/2025
  • 202316/07/2024
  • 202215/07/2023
  • 202114/10/2022
  • 202005/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Top 85%
Voivodeship · Małopolskie37,808 / 46,035
Top 82%
Country · Poland409,421 / 495,867
Top 83%

Results vs industry

Revenue
This companyUSD 9.48kMedianUSD 147.97kAverageUSD 935.17k
Net profit
This companyUSD 0.00MedianUSD 4.21kAverageUSD 56.42k
Operating costs
This companyUSD 9.48kMedianUSD 130.27kAverageUSD 859.59k
Assets
This companyUSD 11.18kMedianUSD 87.27kAverageUSD 779.72k

Authorized Representatives

Bartłomiej Karol Klimas – President of the Management Board
Iwona Gazda Cebula – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Iwona Grażyna Gazda Cebulaage 52
50$675.3125%
Bartłomiej Karol Klimasage 42
15$2,025.9375%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

7 public aid cases recorded, with a total value of $5,475.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,294
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,294
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,294

Competitors

FAQ

Last updated: 2026-04-12